CHESS ROBERT — SEC insider filings
SEC reporting owner CIK 1227886. 39 insider filings on record with FilingPulse; latest filed 2026-09-25.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2020-09-10 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 36 legs across 26 filings — 163,614 shares, $7,143,419 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: sale of 18,417 shares @ $110.89 ($2,042,261) in Twist Bioscience Corp, filed 2026-08-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Twist Bioscience Corp (TWST) | Director | 23 | — | 23 legs · 70,714 sh · $6,073,149 | 17 |
| NEKTAR THERAPEUTICS (NKTR) | Director | 16 | — | 13 legs · 92,900 sh · $1,070,270 | 32 |
Insider filings — CHESS ROBERT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 2,000 @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2026-08-11 | 4 | Twist Bioscience Corp (TWST) | Option exercise (M): 18,417 @ $11.89 · Sale (S): 18,417 @ $110.89 · Option exercise (M): 18,417 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | Twist Bioscience Corp (TWST) | Option exercise (M): 10,000 @ $11.89 · Sale (S): 10,000 @ $47 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 2,184 @ $48.26 | EDGAR |
| 2026-02-09 | 4 | Twist Bioscience Corp (TWST) | Grant/award (A): 5,095 @ $0 | EDGAR |
| 2025-10-01 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 2,940 @ $53.13 | EDGAR |
| 2025-02-07 | 4 | Twist Bioscience Corp (TWST) | Grant/award (A): 4,472 @ $0 | EDGAR |
| 2025-01-10 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 5,000 @ $50 | EDGAR |
| 2024-12-30 | 4 | Twist Bioscience Corp (TWST) | Option exercise (M): 3,504 @ $8.82 · Sale (S): 2,795 @ $51.70 · Sale (S): 709 @ $52.45 · Option exercise (M): 3,504 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | Twist Bioscience Corp (TWST) | Option exercise (M): 3,600 @ $8.82 · Sale (S): 2,324 @ $46.99 · Sale (S): 1,276 @ $47.76 · Option exercise (M): 3,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 19,500 @ $1.20 | EDGAR |
| 2024-02-09 | 4 | Twist Bioscience Corp (TWST) | Grant/award (A): 5,815 @ $0 · Sale (S): 4,110 @ $34.98 | EDGAR |
| 2023-09-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 10,200 @ $0.67 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2023-02-09 | 4 | Twist Bioscience Corp (TWST) | Grant/award (A): 8,212 @ $0 | EDGAR |
| 2022-09-26 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 5,100 @ $3.19 | EDGAR |
| 2022-09-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 10,200 @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Twist Bioscience Corp (TWST) | Grant/award (A): 3,491 @ $0 | EDGAR |
| 2022-02-08 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 253 @ $58.88 | EDGAR |
| 2021-11-03 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 4,000 @ $120.15 | EDGAR |
| 2021-10-25 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 3,700 @ $120.15 | EDGAR |
| 2021-10-21 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 300 @ $120 | EDGAR |
| 2021-09-24 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 10,200 @ $0 · Sale (S): 4,600 @ $17.94 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2021-09-14 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 4,000 @ $120.23 | EDGAR |
| 2021-09-10 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 8,000 @ $13.80 · Sale (S): 8,000 @ $16 · Option exercise (M): 10,279 @ $13.80 · Sale (S): 10,279 @ $16.02 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,279 (derivative) @ $0 | EDGAR |
| 2021-08-26 | 4 | NEKTAR THERAPEUTICS (NKTR) | Gift (G): 6,300 @ $0 · Gift (G): 2,100 @ $0 · Gift (G): 2,100 @ $0 · Gift (G): 2,100 @ $0 | EDGAR |
| 2021-07-22 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 2,106 @ $13.80 · Sale (S): 2,106 @ $16.80 · Option exercise (M): 3,524 @ $13.80 · Sale (S): 3,524 @ $16.81 · Option exercise (M): 91 @ $13.80 · Sale (S): 91 @ $16.80 · +3 more | EDGAR |
| 2021-07-14 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 610 @ $124.37 · Sale (S): 2,495 @ $125.45 · Sale (S): 155 @ $126.00 · Sale (S): 200 @ $127.14 · Sale (S): 300 @ $128.38 · Sale (S): 240 @ $130.46 | EDGAR |
| 2021-06-25 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 4,000 @ $120.10 | EDGAR |
| 2021-05-14 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 8,000 @ $13.80 · Sale (S): 8,000 @ $19.34 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2021-04-16 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 8,000 @ $13.80 · Sale (S): 8,000 @ $18.98 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2021-03-05 | 4/A | Twist Bioscience Corp (TWST) | Grant/award (A): 10,588 (derivative) @ $0 | EDGAR |
| 2021-03-05 | 4/A | Twist Bioscience Corp (TWST) | Grant/award (A): 11,297 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | Twist Bioscience Corp (TWST) | Sale (S): 706 @ $159.54 | EDGAR |
| 2021-02-05 | 4 | Twist Bioscience Corp (TWST) | Grant/award (A): 486 @ $0 · Grant/award (A): 973 (derivative) @ $0 | EDGAR |
| 2020-09-25 | 4/A | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0 | EDGAR |
| 2020-09-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 5,500 @ $17.75 | EDGAR |
| 2020-09-24 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0 | EDGAR |
| 2020-09-10 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 8,000 @ $9.24 · Sale (S): 8,000 @ $18.53 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1227886 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs